image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

Progesterone receptor

Systematic Nomenclature: NR3C3

Family: 3C. 3-Ketosteroid receptors

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Selected 3D Structures
Agonists
Antagonists
DNA Binding
Co-binding Partners
Main Co-regulators
Main Target Genes
Tissue Distribution
Functional Assays
Physiological Consequences of Altering Gene Expression
Phenotypes, Alleles and Disease Models
Clinically-Relevant Mutations and Pathophysiology
Biologically Significant Variants
References
Gene and Protein Information
Species AA Chromosomal Location Gene Symbol Gene Name Reference
Human 933 11q22-q23 PGR progesterone receptor 26
Mouse 926 9A1 Pgr progesterone receptor 28
Rat 923 8q11 Pgr progesterone receptor 15
Previous and Unofficial Names
PR
PGR
Progesterone
NR3C3
nuclear receptor subfamily 3 group C member 3
progesterone receptor
progestin receptor form A
progestin receptor form B
PR-A
PR-B
ENSMUSG00000074510
9930019P03Rik
BB114106
Database Links
ChEMBL Target
DrugBank Target
Ensembl
Entrez Gene
GeneCards
GenitoUrinary Development Molecular Anatomy Project
HomoloGene
Human Protein Reference Database
InterPro
KEGG Gene
NURSA Receptor
OMIM
PharmGKB Gene
PhosphoSitePlus
RefSeq Nucleotide
RefSeq Protein
TreeFam
UniProt
Selected 3D Structures
Image of receptor 3D structure from RCSB PDB
Description:  Progesterone receptor-ligand-binding domain bound to an agonist
PDB Id:  3D90
Ligand:  levonorgestrel
Resolution:  2.26Å
Species:  Human
References:  31
Search for other structures on the PDB
Search by keyword: Progesterone receptor
Natural/Endogenous Ligand(s)
progesterone
Rank order of potency (Human)
Agonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
dydrogesterone Hs Agonist - - 35
levonorgestrel Hs Agonist - - 35
medroxyprogesterone Hs Agonist - - 35
mifepristone Hs Mixed - - 35
norethisterone Hs Agonist - - 35
progesterone Hs Agonist - - 35
promegestone Hs Agonist - - 35
Agonist Comments
All bind in the low to high nanomolar range but reported values range widely depending on assay conditions.
Antagonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
asoprisnil Hs Antagonist - - 35
mifepristone Hs Mixed - - 35
onapristone Hs Inverse agonist - - 35
Antagonist Comments
Binding affinity depends upon the assay and laboratory measuring it, thus the compounds are ranked in order of binding affinity using relative binding affinity (RBA). All bind in the low to high nanomolar range. Mifepristone and Asoprisnil possess tissue specific partial agonist activity.
DNA Binding
Structure:  Homodimer
HRE core sequence:  GGTACANNNTGTTCT
Response element:  GRE, Palindrome
DNA Binding Comments
Highly purified PR binds its response element with low affinity. Addition of nuclear extract or purified HMGB restores DNA binding affinity. In addition to direct response elements, PR can influence gene expression through a "tethering mechanism" independent of PR DNA binding by interacting with other DNA bound transcription factors.
Co-binding Partners
Name Interaction Effect Reference
Hsp90 Physical Cellular localization 10,42
HMGB Physical, Functional DNA binding 5,29
Src family kinases Physical activation of rapid signaling cascades, independent of PR DNA binding. 6
Main Co-regulators
Name Activity Specific Ligand dependent AF-2 dependent Comments References
NCOA1 Co-activator No Yes Yes Steroid-receptor coactivator-1 (SRC-1) appears to be a general coactivator for steroid receptors, preferred member of the p160 family for PR 20,22,36,38,41
NCOA3 Co-activator Yes Yes No 1,7
CREBBP Co-activator No Yes No CBP acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription, and binds as a multimeric complex with SRCs 7,40
SRA1 Co-activator No Yes No 19,37
NCOR2 Co-repressor No Yes Yes Nucleating platform to recruit histone deacetylase complexes. Binds in the presence of antagonist or the absence of hormone 12,21,27,46
JDP2 Co-activator Yes Yes No coactivates agonist or partial agonist mediated activity through an allosteric mechanism 47
Main Target Genes
Name Species Effect Technique Comments References
multidrug resistance 1B Mouse Activated Transient transfection observed in endometrial hyperplasia, induced by PRA only 24
STAT5A Human Activated induced by PRB only in human breast cancer cells as detected by gene array 32
HSD11B1 Human Activated HSD11B1 (11beta-hydroxysteroid dehydrogenase) is induced by both PRA and PRB in gene array analysis of human breast cancer cells 32
Ihh Mouse Activated Indian hedgehog (Ihh) is induced in overiectomized mice 3 hours after administration of progesterone 43
Main Target Genes Comments
Another gene activated by PR is FSH-beta (follicle stimulating hormone beta) , this has been demostrated in sheep [48]
Tissue Distribution
mammary gland, uterus, brain, muscle, testis, ovary
Species:  Human
Technique:  Northern, In situ, Western, Immunohistology
References:  25,33
Tissue Distribution Comments
Both isoforms, PR-A and B, are generally expressed at equivalent levels. PR-A:B ratios can fluctuation in endometrial tissue throughout estrus/menstrual cycle progression, and ratios also can be perturbed in breast cancer and endometriosis. Similar expression patterns are seen in rodents.
Functional Assays
progesterone treatment of estrogen treated ovariectomized mice results in decidualization of the endometrium
Species:  Mouse
Tissue:  uterus
Response measured:  the inhibition of proliferation of the endometrial cells concurrent with differentation
References:  11,30
Cell proliferation - treatment of PR positive breast cancer cells induces cell division
Species:  Human
Tissue:  breast cancer cells and normal breast epithelial cells
Response measured:  cell proliferation
References:  18,34
mammary gland ductal tree branching and lobuloalveolar development
Species:  Mouse
Tissue:  mammary gland
Response measured:  mammary gland development
References:  3,14
Physiological Consequences of Altering Gene Expression
Null mice: disruption of both PRA and B isoforms results in impaired sexual behavior, anovulation, uterine dysfunction, and reduced ductal branching and lobuloalveolar development in the mammary gland.
Species:  Mouse
Tissue: 
Technique:  Gene knockout
References:  23
targeted overexpression of PRA in the mammary gland results in reduced induction of apoptosis
Species:  Mouse
Tissue: 
Technique:  targeted overexpression
References:  39
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0004883 abnormal blood vessel healing PMID: 11518735 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0008271 abnormal bone ossification PMID: 18276762 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0000662 abnormal branching of the mammary ductal tree PMID: 7557380 
Pgrtm2Omc Pgrtm2Omc/Pgrtm2Omc
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0000662 abnormal branching of the mammary ductal tree PMID: 12897242 
Ncoa2tm1.1Ipc|Pgr+|Pgrtm2(cre)Lyd Ncoa2tm1.1Ipc/Ncoa2tm1.1Ipc,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
MGI:1276533  MGI:97567  MP:0000662 abnormal branching of the mammary ductal tree PMID: 17045797 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0000130 abnormal cancellous bone morphology PMID: 18276762 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd
MGI:97567  MP:0003009 abnormal cytokine secretion PMID: 18026113 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0003845 abnormal decidualization PMID: 7557380 
Pgrtm1Omc Pgrtm1Omc/Pgrtm1Omc
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0003845 abnormal decidualization PMID: 10976068 
Ncoa2tm1.1Ipc|Pgr+|Pgrtm2(cre)Lyd Ncoa2tm1.1Ipc/Ncoa2tm1.1Ipc,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
MGI:1276533  MGI:97567  MP:0003845 abnormal decidualization PMID: 17045797 
Ncoa1tm1Bwo|Ncoa2tm1.1Ipc|Pgr+|Pgrtm2(cre)Lyd Ncoa1tm1Bwo/Ncoa1tm1Bwo,Ncoa2tm1.1Ipc/Ncoa2tm1.1Ipc,Pgrtm2(cre)Lyd/Pgr+
involves: 129/Sv * 129S1/Sv * 129S2/SvPas * 129X1/SvJ
MGI:1276523  MGI:1276533  MGI:97567  MP:0003845 abnormal decidualization PMID: 17045797 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0009095 abnormal endometrial gland number PMID: 19439667 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001119 abnormal female reproductive system morphology PMID: 12403837 
Pgrtm3(rtTA2S*M2)Lyd Pgrtm3(rtTA2S*M2)Lyd/Pgrtm3(rtTA2S*M2)Lyd
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
MGI:97567  MP:0001119 abnormal female reproductive system morphology PMID: 17941046 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0003967 abnormal follicle stimulating hormone level PMID: 10433223 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0005296 abnormal humerus morphology PMID: 18276762 
Pgrtm2Omc Pgrtm2Omc/Pgrtm2Omc
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001882 abnormal lactation PMID: 12897242 
Pgrtm2Omc Pgrtm2Omc/Pgrtm2Omc
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0009506 abnormal mammary gland alveolus morphology PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0009506 abnormal mammary gland alveolus morphology PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0000628 abnormal mammary gland development PMID: 7557380 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0000628 abnormal mammary gland development PMID: 12403837 
Pgrtm2Omc Pgrtm2Omc/Pgrtm2Omc
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0009504 abnormal mammary gland epithelium morphology PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0009504 abnormal mammary gland epithelium morphology PMID: 14667968 
Pgrtm2Omc Pgrtm2Omc/Pgrtm2Omc
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0006269 abnormal mammary gland growth during pregnancy PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0001881 abnormal mammary gland physiology PMID: 20029965 
Pgrtm4.2Lyd Pgrtm4.2Lyd/Pgrtm4.2Lyd
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 * FVB/N
MGI:97567  MP:0001881 abnormal mammary gland physiology PMID: 20029965 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0001376 abnormal mating receptivity PMID: 7557380 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0004982 abnormal osteoclast morphology PMID: 18276762 
Pgrtm1Omc Pgrtm1Omc/Pgrtm1Omc
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0001928 abnormal ovulation PMID: 10976068 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001928 abnormal ovulation PMID: 12403837 
Pgrtm1.2Mlia Pgrtm1.2Mlia/Pgrtm1.2Mlia
involves: 129 * C57BL/6J
MGI:97567  MP:0001928 abnormal ovulation PMID: 16868919 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0003562 abnormal pancreatic beta cell physiology PMID: 12438645 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001919 abnormal reproductive system physiology PMID: 12403837 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0003638 abnormal response/metabolism to endogenous compounds PMID: 11518735 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0002566 abnormal sexual interaction PMID: 12403837 
Pgrtm3(rtTA2S*M2)Lyd Pgrtm3(rtTA2S*M2)Lyd/Pgrtm3(rtTA2S*M2)Lyd
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
MGI:97567  MP:0002566 abnormal sexual interaction PMID: 17941046 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0000558 abnormal tibia morphology PMID: 18276762 
Pgrtm1Omc Pgrtm1Omc/Pgrtm1Omc
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0004014 abnormal uterine environment PMID: 10976068 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0001120 abnormal uterus morphology PMID: 7557380 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0001120 abnormal uterus morphology PMID: 19439667 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0009671 abnormal uterus physiology PMID: 20029965 
Pgrtm4.2Lyd Pgrtm4.2Lyd/Pgrtm4.2Lyd
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 * FVB/N
MGI:97567  MP:0009671 abnormal uterus physiology PMID: 20029965 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0001134 absent corpus luteum PMID: 7557380 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001134 absent corpus luteum PMID: 12403837 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0008869 anovulation PMID: 7557380 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0008869 anovulation PMID: 20029965 
Pgrtm4.2Lyd Pgrtm4.2Lyd/Pgrtm4.2Lyd
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6 * FVB/N
MGI:97567  MP:0008869 anovulation PMID: 20029965 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0005560 decreased circulating glucose level PMID: 12438645 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0002773 decreased circulating luteinizing hormone level PMID: 10433223 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0002053 decreased incidence of induced tumors PMID: 14667968 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0010174 decreased mammary gland epithelium proliferation PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0001123 dilated uterus PMID: 7557380 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
MGI:109583  MGI:97567  MP:0004868 endometrial carcinoma PMID: 18632614 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu|Trp53tm1Brn Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu,Trp53tm1Brn/Trp53tm1Brn
involves: 129 * C57BL/6
MGI:109583  MGI:97567  MGI:98834  MP:0004868 endometrial carcinoma PMID: 18632614 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0004868 endometrial carcinoma PMID: 19439667 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
MGI:109583  MGI:97567  MP:0009092 endometrium hyperplasia PMID: 18632614 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu|Trp53tm1Brn Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu,Trp53tm1Brn/Trp53tm1Brn
involves: 129 * C57BL/6
MGI:109583  MGI:97567  MGI:98834  MP:0009092 endometrium hyperplasia PMID: 18632614 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0009092 endometrium hyperplasia PMID: 19439667 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0009251 enlarged endometrial glands PMID: 7557380 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu|Trp53tm1Brn Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu,Trp53tm1Brn/Trp53tm1Brn
involves: 129 * C57BL/6
MGI:109583  MGI:97567  MGI:98834  MP:0004906 enlarged uterus PMID: 18632614 
Ncoa2tm1.1Ipc|Pgr+|Pgrtm2(cre)Lyd Ncoa2tm1.1Ipc/Ncoa2tm1.1Ipc,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
MGI:1276533  MGI:97567  MP:0001728 failure of embryo implantation PMID: 17045797 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0001926 female infertility PMID: 7557380 
Pgrtm1Omc Pgrtm1Omc/Pgrtm1Omc
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0001926 female infertility PMID: 10976068 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0001926 female infertility PMID: 12403837 
Pgrtm1.2Mlia Pgrtm1.2Mlia/Pgrtm1.2Mlia
involves: 129 * C57BL/6J
MGI:97567  MP:0001926 female infertility PMID: 16868919 
Ncoa2tm1.1Ipc|Pgr+|Pgrtm2(cre)Lyd Ncoa2tm1.1Ipc/Ncoa2tm1.1Ipc,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
MGI:1276533  MGI:97567  MP:0001926 female infertility PMID: 17045797 
Pgrtm3(rtTA2S*M2)Lyd Pgrtm3(rtTA2S*M2)Lyd/Pgrtm3(rtTA2S*M2)Lyd
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
MGI:97567  MP:0001926 female infertility PMID: 17941046 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0001926 female infertility PMID: 19439667 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0003356 impaired luteinization PMID: 7557380 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0005292 improved glucose tolerance PMID: 12438645 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0005605 increased bone mass PMID: 18276762 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0009347 increased cancellous bone thickness PMID: 18276762 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0002079 increased circulating insulin level PMID: 12438645 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0005124 increased circulating prolactin level PMID: 12897242 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0004148 increased cortical bone thickness PMID: 18276762 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0003058 increased insulin secretion PMID: 12438645 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0008870 increased mature ovarian follicle number PMID: 7557380 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0003645 increased pancreatic beta cell number PMID: 12438645 
Errfi1tm1Jwj|Pgr+|Pgrtm2(cre)Lyd Errfi1tm1Jwj/Errfi1tm1Jwj,Pgrtm2(cre)Lyd/Pgr+
involves: 129S1/Sv * 129X1/SvJ
MGI:1921405  MGI:97567  MP:0004904 increased uterus weight PMID: 19439667 
Pgr+|Pgrtm1Lyd Pgrtm1Lyd/Pgr+
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0002169 no abnormal phenotype detected PMID: 12403837 
Pgrtm1.1Mlia Pgrtm1.1Mlia/Pgrtm1.1Mlia
involves: 129 * C57BL/6J
MGI:97567  MP:0002169 no abnormal phenotype detected PMID: 16868919 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0005491 pancreatic islet hyperplasia PMID: 12438645 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
MGI:109583  MGI:97567  MP:0002083 premature death PMID: 18632614 
Pgr+|Pgrtm2(cre)Lyd|Ptentm1Hwu|Trp53tm1Brn Pgrtm2(cre)Lyd/Pgr+,Ptentm1Hwu/Ptentm1Hwu,Trp53tm1Brn/Trp53tm1Brn
involves: 129 * C57BL/6
MGI:109583  MGI:97567  MGI:98834  MP:0002083 premature death PMID: 18632614 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0002676 uterus hyperplasia PMID: 7557380 
Pgrtm1Omc Pgrtm1Omc/Pgrtm1Omc
involves: 129S7/SvEvBrd * C57BL/6J
MGI:97567  MP:0002676 uterus hyperplasia PMID: 10976068 
Pgrtm1Lyd Pgrtm1Lyd/Pgrtm1Lyd
involves: 129S7/SvEvBrd * C57BL/6
MGI:97567  MP:0002676 uterus hyperplasia PMID: 12403837 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)
MGI:97567  MP:0009080 uterus inflammation PMID: 7557380 
Pgrtm1Bwo Pgrtm1Bwo/Pgrtm1Bwo
involves: 129S7/SvEvBrd
MGI:97567  MP:0005489 vascular smooth muscle cell hyperplasia PMID: 11518735 
Clinically-Relevant Mutations and Pathophysiology
Disease:  Pseudocorpus luteum insufficiency
OMIM: 
Role: 
Comments: 
References:  17
Mutations not determined
Disease:  breast cancer
Comments: 
References:  4
Mutations not determined
Disease:  Endometriosis
OMIM: 
Role: 
Drugs: 
Comments: 
References:  2,8
Mutations not determined
Disease:  endometrial cancer
OMIM: 
Comments: 
References:  9,44
Mutations not determined
Biologically Significant Variants
PR-B (progesterone receptor isoform B) is the full-length protein which strongly activates target genes  
Protein accession:  NP_000917 
Type:  Splice variant
Species:  Human
References:  16
PR-A (progesterone receptor isoform A):- N-terminally truncated isoform that is a weak transcriptional activator of specific target genes in a cell type dependent manner and also a strong repressor of transactivation by PRB and other steroid receptors
Type:  Splice variant
Species:  Human
References:  13,16,45

REFERENCES

To cite this database page, please use the following:

3C. 3-Ketosteroid receptors: Progesterone receptor. Last modified on 01/03/2012. Accessed on 23/05/2013. IUPHAR database (IUPHAR-DB), http://iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=627.


Contact us | Print | Back to top | Help